SCH 14A_1074

Company

Sarepta Therapeutics, Inc.

Filed

April 16, 2001

Period of Report

May 17, 2001

Accession Number

0000912057-01-508820

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →